OSD: A Review
By Ahmad M. Fahmy, OD, FAAO, Dipl ABO
In 2015, clinical research and innovation in point-of-care diagnostics contributed to continued evolution in the diagnosis and treatment of ocular surface disease (OSD), prompting clinicians to consider how to utilize these new tools, data, and therapies. Dr. Fahmy reviews some of the latest technologies available for OSD diagnosis and treatment and offers his own observations about how best to put them into practice.
My Algorithm for DED
By Neda Shamie, MD; Alice T. Epitropoulos, MD;
Elizabeth L. Yeu, MD; P. Dee G. Stephenson, MD;
Sheri Rowen, MD; and Cathleen McCabe, MD
Dry eye disease (DED) can be extremely burdensome for both the doctor and the patient; however, its diagnosis and management have blossomed in the past several years. Drs. Shamie, Epitropoulos, Yeu, Stephenson, Rowen, and McCabe detail their approaches to evaluating the ocular surface and deconstruct their go-to therapies for managing DED.
Focus on Phaco
Point/Counterpoint: Do I Really Need a New Phaco Machine?
By Damien F. Goldberg, MD; and William J. Lahners, MD
When contemplating implementing a new technology into practice, surgeons must often pit the benefits against the costs. Drs. Goldberg and Lahners debate the necessity of having the latest phaco technology and whether the capabilities afforded by an upgraded system outweigh the financial implications of its adoption.
Is Less Better?
By Michael Collins, MD; James C. Loden, MD;
and Steven G. Safran, MD
In the ongoing debate over the merits of laser-assisted cataract surgery, one argument for the benefit of the procedure is the potential decrease in ultrasound energy needed to remove the cataract. Drs. Collins, Loden, and Safran weigh in on whether the femtosecond laser truly makes cataract surgery better by decreasing phacoemulsification time and whether the clinical value is great enough to warrant the risks and costs associated with the procedure.